37111 Stories, most recent news story added 2 minutes ago
Zacks Analyst Blog Highlights: Humana Inc., CVS Caremark, Aetna Inc., CIGNA Corp. and UnitedHealth Group, Inc.
The health insurance industry on Thursday struck back at provisions in Congress' healthcare proposals that it said would do little to curb the nation's spiraling costs or provide people more affordable coverage.
Aetna fell $.55 or 1.8 percent, to $29.21. CIGNA fell $.55 or 1.6 percent, to $32.82.
Despite the FDA's recent rejection of experimental drug Ampligen, Hemispherx's CEO remains optimistic.
Gov.-elect Chris Christie has named four of his top advisers, including three with legal backgrounds. Richard Bagger, 49, a Pfizer executive and former state legislator, was chosen as chief of staff -- considered the most powerful position in the governor's inner office.
FDA recently approved Santarus' over-the-counter version of Zegerid for the treatment of frequent heartburn.
Dec. 4 (Bloomberg) -- Shares of the following companies may have unusual moves in U.S. trading . Stock symbols are in parentheses, and prices are as of 9 a.m. in New York.
Seven Summits Research issues PriceWatch Alerts for COF, PG, FDX, GENZ, and HUM.
Alexion Pharmaceutic Rhode Island manufacturing facility should be up and running shortly as a second source of supply for the drug Soliris
By insider. Sr. VP, CFO & Treasurer of Humana Inc. ( HUM ) James H Bloem sells 45,000 shares of HUM on 12/02/2009 at an average price of $42.49 a share. Read more » »
Senator Ben Nelson , a Nebraska Democrat, threatened to join with Republicans to vote against the final measure unless he’s satisfied with language preventing federal funds from being used for the procedure. He may soon offer an amendment to bring language in the bill in line with a House provision.
CAPITOL BRIEFING | In 58 to 42 vote, senators keep nearly $500B in cuts, protecting the bill's major source of financing against a Republican attack.
OKLAHOMA CITY — More people are enrolled in Oklahoma's Medicaid program than ever before, but ...
Unflinching on a critical first test, Senate Democrats closed ranks Thursday behind $460 billion in politically risky Medicare cuts at the heart of health care legislation, thwarting a Republican attempt to doom President Barack Obama's sweeping overhaul.
Pharmaceutical company AstraZeneca PLC said Friday it has won U.S. approval for use of its schizophrenia drug Seroquel XR as an add-on treament for major depressive disorder.
Biotech reporter Adam Feuerstein answers reader email about Hemispherx Biopharma, Cel-Sci and other stocks.
